Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences
" "
FOOD AND DRUG ADMINISTRATION
FOR IMMEDIATE RELEASE
Consumer Media: 888-Info-FDA
June 30, 1999

Teva Pharmaceuticals Recalls Cephradine Capsules

Sellersville, PA (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that Teva Pharmaceuticals, USA, Inc. is recalling Cephradine Capsules because of Subpotency (stability).

PRODUCT
Cephradine Capsules USP, 250 mg in bottles of 100, Rx indicated in the treatment of respiratory tract infection, otitis media, skin and skin-structure infections, and urinary tract infections. NDC #0093-3153-01.

Recall #D-274-9.

CODE
Lot #56214 EXP 9/99.

MANUFACTURER
Teva Pharmaceuticals, USA, Inc., Sellersville, Pennsylvania.

RECALLED BY
Manufacturer, by letter on June 15, 1999. Firm-initiated recall ongoing.

DISTRIBUTION
Nationwide.

QUANTITY
Approximately 10,852 bottles were distributed; firm estimated that 2,700 bottles remained on market at time of recall initiation.

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.